Aton (BST:3HB)

Germany · Delayed Price · Currency is EUR

0.0060

0.00 (0.00%)

At close: Aug 10, 2026

87.50% (1Y)

Market Cap	9.61M +43.6%
Revenue (ttm)	656.93K +102.0%
Net Income	-115.68K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150,000
Open	0.0060
Previous Close	0.0060
Day's Range	0.0060 - 0.0116
52-Week Range	0.0002 - 0.0258
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1998

Employees 9

Stock Exchange Stuttgart Stock Exchange

Ticker Symbol 3HB

Financial Performance

In 2024, Aton's revenue was 614,000, an increase of 0.33% compared to the previous year's 612,000. Losses were -1.10 million, -86.01% less than in 2023.

Financial Statements